Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and over treatment of prostate cancer has g...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Sahoo, Debashis, Wei, Wei, Auman, Heidi, Hurtado-Coll, Antonio, Carroll, Peter R., Fazli, Ladan, Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Simko, Jeff, Thompson, Ian M., Leach, Robin J., Troyer, Dean A., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Brooks, James D.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814231/
https://ncbi.nlm.nih.gov/pubmed/29464091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23973
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky